title: RET signaling in endocrine tumors: delving deeper into molecular mechanisms.
abstract: The rearranged during transfection (RET) proto-oncogene encodes a receptor tyrosine kinase that is implicated in the development of endocrine tumors of the thyroid and adrenal glands. In humans, activating RET mutations are found in the inherited cancer syndrome multiple endocrine neoplasia 2 and in sporadic medullary and papillary thyroid carcinomas. The specific type and location of RET mutations are strongly correlated with the disease phenotype and have both diagnostic and prognostic value. Recent advances in the molecular characterization of the RET receptor and its mutants have begun to define the mechanisms underlying the transforming ability of the different RET mutant forms. This information has revealed key functional features of these mutant proteins that distinguish the different clinically recognized mutations and provide clues as to the functional origins of the phenotypes associated with specific RET mutations. The elucidation of molecular mechanisms involved in RET-mediated transformation is a key step in the development of much needed therapeutics that target RET's oncogenic properties. Recent advances have begun to provide a deeper understanding of the receptor's function, and dysfunction, in human tumors that may guide this process.
authors.affiliation: Division of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Botterell Hall Rm 329, Kingston, ON, K7L 3N6, Canada.
authors.forename: Andrea Z
authors.initials: AZ
authors.lastname: Lai
authors.forename: Taranjit S
authors.initials: TS
authors.lastname: Gujral
authors.forename: Lois M
authors.initials: LM
authors.lastname: Mulligan
mesh_terms: D000818:Animals; D004701:Endocrine Gland Neoplasms / Q000235:genetics* / Q000503:physiopathology*; D006801:Humans; D008958:Models, Molecular; D018813:Multiple Endocrine Neoplasia Type 2a / Q000235:genetics / Q000503:physiopathology; D009154:Mutation / Q000235:genetics / Q000502:physiology; D000090063:Proto-Oncogene Mas; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics* / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics* / Q000502:physiology*
chemical_list: C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D051096:Proto-Oncogene Proteins c-ret